Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

United Therapeutics (UTHR) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for United Therapeutics (UTHR) over the last 14 years, with Q4 2022 value amounting to $72.7 million.

  • United Therapeutics' Shares Outstanding rose 139.47% to $72.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $72.7 million, marking a year-over-year increase of 139.47%. This contributed to the annual value of $72.7 million for FY2022, which is 139.47% up from last year.
  • Latest data reveals that United Therapeutics reported Shares Outstanding of $72.7 million as of Q4 2022, which was up 139.47% from $72.1 million recorded in Q2 2022.
  • In the past 5 years, United Therapeutics' Shares Outstanding registered a high of $72.7 million during Q4 2022, and its lowest value of $70.1 million during Q1 2018.
  • For the 5-year period, United Therapeutics' Shares Outstanding averaged around $71.0 million, with its median value being $71.0 million (2020).
  • Per our database at Business Quant, United Therapeutics' Shares Outstanding increased by 28.41% in 2020 and then surged by 139.47% in 2022.
  • Over the past 5 years, United Therapeutics' Shares Outstanding (Quarter) stood at $70.2 million in 2018, then rose by 0.43% to $70.5 million in 2019, then grew by 0.85% to $71.1 million in 2020, then grew by 0.84% to $71.7 million in 2021, then increased by 1.39% to $72.7 million in 2022.
  • Its Shares Outstanding was $72.7 million in Q4 2022, compared to $72.1 million in Q2 2022 and $71.9 million in Q1 2022.